Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes

医学 脱胶胰岛素 甘精胰岛素 低血糖 胰岛素 血糖性 糖尿病 内科学 2型糖尿病 早晨 随机对照试验 1型糖尿病 交叉研究 傍晚 内分泌学 儿科 安慰剂 替代医学 病理 物理 天文
作者
Carol Wysham,Anuj Bhargava,Louis Chaykin,Raymond de la Rosa,Yehuda Handelsman,Lone Troelsen,Kajsa Kvist,Paul Norwood
出处
期刊:JAMA [American Medical Association]
卷期号:318 (1): 45-45 被引量:200
标识
DOI:10.1001/jama.2017.7117
摘要

Importance

Hypoglycemia, a serious risk for insulin-treated patients with type 2 diabetes, negatively affects glycemic control.

Objective

To test whether treatment with basal insulin degludec is associated with a lower rate of hypoglycemia compared with insulin glargine U100 in patients with type 2 diabetes.

Design, Setting, and Participants

Randomized, double-blind, treat-to-target crossover trial including two 32-week treatment periods, each with a 16-week titration period and a 16-week maintenance period. The trial was conducted at 152 US centers between January 2014 and December 2015 in 721 adults with type 2 diabetes and at least 1 hypoglycemia risk factor who were previously treated with basal insulin with or without oral antidiabetic drugs.

Interventions

Patients were randomized 1:1 to receive once-daily insulin degludec followed by insulin glargine U100 (n = 361) or to receive insulin glargine U100 followed by insulin degludec (n = 360) and randomized 1:1 to morning or evening dosing within each treatment sequence.

Main Outcomes and Measures

The primary end point was the rate of overall symptomatic hypoglycemic episodes (severe or blood glucose confirmed [<56 mg/dL]) during the maintenance period. Secondary end points were the rate of nocturnal symptomatic hypoglycemic episodes (severe or blood glucose confirmed, occurring between 12:01amand 5:59am) and the proportion of patients with severe hypoglycemia during the maintenance period.

Results

Of the 721 patients randomized (mean [SD] age, 61.4 [10.5] years; 53.1% male), 580 (80.4%) completed the trial. During the maintenance period, the rates of overall symptomatic hypoglycemia for insulin degludec vs insulin glargine U100 were 185.6 vs 265.4 episodes per 100 patient-years of exposure (PYE) (rate ratio = 0.70 [95% CI, 0.61-0.80];P < .001; difference, −23.66 episodes/100 PYE [95% CI, −33.98 to −13.33]), and the proportions of patients with hypoglycemic episodes were 22.5% vs 31.6% (difference, −9.1% [95% CI, −13.1% to −5.0%]). The rates of nocturnal symptomatic hypoglycemia with insulin degludec vs insulin glargine U100 were 55.2 vs 93.6 episodes/100 PYE (rate ratio = 0.58 [95% CI, 0.46-0.74];P < .001; difference, −7.41 episodes/100 PYE [95% CI, −11.98 to −2.85]), and the proportions of patients with hypoglycemic episodes were 9.7% vs 14.7% (difference, −5.1% [95% CI, −8.1% to −2.0%]). The proportions of patients experiencing severe hypoglycemia during the maintenance period were 1.6% (95% CI, 0.6%-2.7%) for insulin degludec vs 2.4% (95% CI, 1.1%-3.7%) for insulin glargine U100 (McNemarP = .35; risk difference, −0.8% [95% CI, −2.2% to 0.5%]). Statistically significant reductions in overall and nocturnal symptomatic hypoglycemia for insulin degludec vs insulin glargine U100 were also seen for the full treatment period.

Conclusions and Relevance

Among patients with type 2 diabetes treated with insulin and with at least 1 hypoglycemia risk factor, 32 weeks’ treatment with insulin degludec vs insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemia.

Trial Registration

clinicaltrials.gov Identifier:NCT02030600
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
kaga发布了新的文献求助10
刚刚
大方树叶发布了新的文献求助30
1秒前
Allenlee完成签到,获得积分10
1秒前
1秒前
学生守则完成签到,获得积分10
2秒前
曦浅发布了新的文献求助10
2秒前
麦克雷发布了新的文献求助10
2秒前
斯文败类的应助被叾屾采纳,获得10
2秒前
Jasper的应助被chen采纳,获得10
2秒前
天天快乐的应助被tangtang987采纳,获得10
3秒前
3秒前
ZHUPF发布了新的文献求助30
3秒前
3秒前
Lucas的应助被xjc23采纳,获得10
3秒前
4秒前
4秒前
FU完成签到,获得积分10
4秒前
4秒前
5秒前
5秒前
5秒前
5秒前
粗去丸完成签到,获得积分10
5秒前
老实狗完成签到,获得积分10
5秒前
蓝天的应助被zhawenchang采纳,获得10
6秒前
6秒前
神秘Q完成签到,获得积分20
6秒前
肉丸111发布了新的文献求助10
7秒前
xx完成签到 ,获得积分10
7秒前
现代的盼夏完成签到,获得积分10
8秒前
传奇3的应助被zmy采纳,获得10
8秒前
未见阑珊完成签到,获得积分10
8秒前
Lucas的应助被武淑晴采纳,获得20
8秒前
8秒前
9秒前
老实狗发布了新的文献求助10
9秒前
9秒前
cc6521发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8154217
求助须知:如何正确求助?哪些是违规求助? 9550722
关于积分的说明 21700876
捐赠科研通 7743358
什么是DOI,文献DOI怎么找? 3425651
关于科研通互助平台的介绍 2550897
邀请新用户注册赠送积分活动 2469372